Stay updated on RESILIENT Clinical Trial
Sign up to get notified when there's something new on the RESILIENT Clinical Trial page.

Latest updates to the RESILIENT Clinical Trial page
- Check5 days agoChange DetectedA service alert has been added indicating planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference1%
- Check13 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Additionally, a significant piece of information regarding the modernization of ClinicalTrials.gov data ingest in July 2025 has been deleted.SummaryDifference1%
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference1%
- Check34 days agoChange DetectedThe web page has been updated to include detailed information about a clinical study evaluating the efficacy and safety of bimagrumab/BYM338 for patients with sporadic inclusion body myositis, including study design, eligibility criteria, and contact information for study locations.SummaryDifference100%
- Check41 days agoChange DetectedThe web page has undergone significant deletions, removing extensive details about a clinical study on bimagrumab/BYM338, including study design, eligibility criteria, and outcome measures. The only addition noted is a revision number update.SummaryDifference78%
- Check48 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference2%
Stay in the know with updates to RESILIENT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RESILIENT Clinical Trial page.